For research use only. We do not sell to patients.
BrBzGCp2
CAS No. : 166038-00-2
Biological Activity:BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activity[2].
Research Area:Cancer|Neurological Disease
Targets:Glyoxalase (GLO)
Related Screening Libraries:Bioactive Compound Library Plus;Metabolism/Protease Compound Library;Anti-Cancer Compound Library;Anti-diabetic Compound Library;Neuroprotective Compound Library;Targeted Diversity Library;
Related Small Molecules:4BAB;HBPC–GSH;Glyoxalase I inhibitor 3;Glyoxalase I inhibitor 5;Glyoxalase I inhibitor 2;Glyoxalase I inhibitor 1;Glyoxalase I inhibitor 4;S-Sulfo-DL-cysteine-2,3,3-d3;Glyoxalase I inhibitor 6;Glyoxalase I inhibitor 7;Glyoxalase I inhibitor;TS010
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
- Structurally and synthetically diverse biologically active compounds;
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
- Customized order volume ranging from milligrams to kilograms scale;
Structurally and synthetically diverse biologically active compounds;
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.